🚀

오늘의 열정을 계속 이어가세요!

체험은 만족하셨나요? 지식 자료를 소장하고 멋진 의료인으로 성장하세요!

Antineoplastic Medications | 마이메르시 MyMerci
제안하기

Antineoplastic Medications

NCLEX Review Guide: Antineoplastic Medications

Overview of Antineoplastic Medications

Classification and Mechanisms

  • Alkylating agents (cyclophosphamide, cisplatin) work by cross-linking DNA strands, preventing cell replication during any phase of the cell cycle.
  • Antimetabolites (methotrexate, 5-fluorouracil) interfere with DNA synthesis by mimicking normal metabolites required for cell division.
  • Plant alkaloids (vincristine, paclitaxel) disrupt microtubule formation, preventing proper chromosome separation during mitosis.
  • Antitumor antibiotics (doxorubicin, bleomycin) intercalate between DNA base pairs and generate free radicals that damage cellular components.

Key Points

  • Antineoplastic drugs target rapidly dividing cells, affecting both cancerous and normal cells
  • Most effective against cells in active phases of cell cycle (S, G2, M phases)
  • Combination therapy increases effectiveness while reducing individual drug toxicity

Major Side Effects and Nursing Interventions

Hematological Toxicity

  • Myelosuppression is the most common dose-limiting toxicity, with nadir (lowest counts) typically occurring 7-14 days post-treatment.
  • Monitor complete blood count (CBC) with differential before each treatment cycle and implement neutropenia precautions when ANC < 1,000.
  • Thrombocytopenia requires bleeding precautions when platelet count falls below 50,000, including soft toothbrush use and avoiding invasive procedures.

Memory Aid: "My Patients Need TLC"

Myelosuppression - Platelet monitoring - Neutropenia precautions - Thrombocytopenia care - Leukopenia awareness - CBC monitoring

Gastrointestinal Toxicity

  • Mucositis and stomatitis commonly occur 5-7 days after treatment, requiring frequent oral care with normal saline rinses and avoiding alcohol-based mouthwashes.
  • Nausea and vomiting management includes prophylactic antiemetics (ondansetron, metoclopramide) administered 30 minutes before chemotherapy.
  • Diarrhea may require fluid and electrolyte replacement, with severe cases needing antidiarrheal medications and dietary modifications.

Drug-Specific Considerations

High-Alert Medications

Clinical Scenario: Doxorubicin Administration

A patient is receiving doxorubicin 60 mg/m² IV. The nurse must monitor for extravasation as this drug is a potent vesicant that can cause severe tissue necrosis if it leaks into surrounding tissues.

  1. Verify patent IV access with blood return before administration
  2. Administer through central line when possible for vesicant drugs
  3. Monitor injection site continuously during infusion
  4. Have antidote readily available (dexrazoxane for anthracyclines)
  5. Stop infusion immediately if extravasation suspected

Organ-Specific Toxicities

  • Cardiotoxicity from doxorubicin requires baseline ECHO or MUGA scan, with cumulative lifetime dose not exceeding 450-550 mg/m².
  • Pulmonary toxicity from bleomycin manifests as pulmonary fibrosis, requiring baseline pulmonary function tests and monitoring for dyspnea.
  • Nephrotoxicity from cisplatin necessitates adequate hydration (1-2L normal saline) before and after administration plus monitoring serum creatinine.
  • Neurotoxicity from vincristine presents as peripheral neuropathy, requiring assessment of deep tendon reflexes and numbness/tingling.

Commonly Confused Concepts

ConceptVesicantIrritantNon-vesicant
DefinitionCauses tissue necrosisCauses inflammationNo tissue damage
ExamplesDoxorubicin, VincristineCarboplatin, PaclitaxelCyclophosphamide
IV AccessCentral line preferredLarge peripheral veinAny patent IV
Extravasation RiskHigh - severe damageModerate - local reactionLow - minimal risk

Common Pitfalls

  • Don't confuse nadir timing - hematologic nadir occurs 7-14 days, not immediately after treatment
  • Remember that fever in neutropenic patients is a medical emergency requiring immediate antibiotic therapy
  • Vesicant extravasation requires immediate intervention - don't wait for symptoms to worsen

Study Tips and Memory Aids

CHEMO Safety Checklist

Check two patient identifiers
Handling precautions (PPE)
Extravasation monitoring
Medication verification (double-check)
Organ toxicity assessment

Quick Check Questions

  • □ Can you identify the four main classes of antineoplastic drugs?
  • □ Do you know when hematologic nadir typically occurs?
  • □ Can you list three vesicant chemotherapy drugs?
  • □ Do you understand neutropenia precautions?
  • □ Can you identify organ-specific toxicities for major drugs?

High-Yield NCLEX Points

  • Neutropenia precautions when ANC < 1,000
  • Vesicant drugs require central line access when possible
  • Doxorubicin has cumulative cardiac toxicity limits
  • Bleomycin causes pulmonary fibrosis, not myelosuppression
  • Cisplatin requires pre/post hydration for nephroprotection

Remember: You're preparing to save lives and provide compassionate care to cancer patients. Master these concepts with confidence - every question you answer correctly brings you closer to becoming the exceptional nurse your patients will need. Stay focused, stay positive, and trust your preparation!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.